Autoantibody profiling to predict response to the anti-PD-1 therapy, pembrolizumab, in rare tumors
利用自身抗体谱预测罕见肿瘤患者对PD-1抑制剂帕博利珠单抗的反应
期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2025.105518
Derbala, M H; Hajjar, J; Stephen, B; Gurses, S A; Kwiatkowski, E; Budde, P; Zucht, H-D; Bräutigam, M; Lindemann, A-S; Abhari, B A; Gouda, M A; Castillo, L; Zarifa, A; How, J A; Rodriguez, E; Moyers, J T; Hong, D S; Fu, S; Meric-Bernstam, F; Naing, A